Severe immune-mediated drug-induced liver injury linked to ibandronate: A case report

Journal of Hepatology

Volumn 59, Issue 5, 2013, Pages 1139-1142

  Goossens, Nicolas ^a   Spahr, Laurent ^a   Rubbia Brandt, Laura ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Bisphosphonate; Drug induced liver injury; Ibandronate

Indexed keywords

ACETYLSALICYLIC ACID; ACTIN ANTIBODY; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; BILIRUBIN; BUDESONIDE; GAMMA GLUTAMYLTRANSFERASE; IBANDRONIC ACID; IMMUNOGLOBULIN G; PREDNISONE; SMOOTH MUSCLE ANTIBODY; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; ASTHENIA; BLEEDING; CASE REPORT; CORTICOSTEROID THERAPY; DRUG WITHDRAWAL; FATIGUE; FEMALE; GENERALIZED EDEMA; HIRSUTISM; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNE MEDIATED DRUG INDUCED LIVER INJURY; LIVER BIOPSY; LIVER FUNCTION TEST; MENTAL INSTABILITY; OSTEOPOROSIS; PRIORITY JOURNAL; SIDE EFFECT; TOXIC HEPATITIS; WEIGHT GAIN;

AIH; ALANINE AMINOTRANSFERASE; ALT; ASPARTATE AMINOTRANSFERASE; AST; AUTO-IMMUNE HEPATITIS; BISPHOSPHONATE; COMPUTED TOMOGRAPHY; CT; DILI; DRUG-INDUCED LIVER INJURY; HIV; HUMAN IMMUNODEFICIENCY VIRUS; IBANDRONATE; LFTS; LIVER FUNCTION TESTS; N; NORMAL; ROUSSEL UCLAF CAUSALITY ASSESSMENT METHOD; RUCAM; ULN; UPPER LIMIT OF NORMAL;

ADRENAL CORTEX HORMONES; DIPHOSPHONATES; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; OSTEOPOROSIS; STEROIDS; TREATMENT OUTCOME; WITHHOLDING TREATMENT;

EID: 84886921769     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.06.003     Document Type: Article

References (27)

1. J.E. Dunford Molecular targets of the nitrogen containing bisphosphonates: the molecular pharmacology of prenyl synthase inhibition Curr Pharm Des 16 2010 2961 2969
2. J.A. Eisman, R. Civitelli, S. Adami, E. Czerwinski, C. Recknor, and R. Prince Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study J Rheumatol 35 2008 488 497
3. C.H. Chesnut, M.P. Ettinger, P.D. Miller, D.J. Baylink, R. Emkey, and S.T. Harris Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from bone Curr Med Res Opin 21 2005 391 401
4. C. Carrere, J.L. Duval, B. Godard, J.P. De Jaureguiberry, and J.M. Ciribilli Severe acute hepatitis induced by alendronate Gastroenterol Clin Biol 26 2002 179 180
5. C. de La Serna Higuera, A. Perez Villoria, S. Rodriguez Gomez, J. Martinez Moreno, A. Betancourt Gonzalez, and M. Martin Arribas Alendronate-induced hepatocellular lesion Gastroenterol Hepatol 24 2001 244 246
6. A. Halabe, B.M. Lifschitz, and J. Azuri Liver damage due to alendronate N Engl J Med 343 2000 365 366
7. K. Laitinen, and T. Taube Clodronate as a cause of aminotransferase elevation Osteoporos Int 10 1999 120 122
8. R.J. Lieverse Hepatitis after alendronate Neth J Med 53 1998 271 272
9. M.B. Phillips Risedronate-induced hepatitis Am J Med 120 2007 e1 e2
10. S.A. Polyzos, J. Kountouras, A.D. Anastasilakis, I. Litsas, M. Kita, and G. Arsos Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of bone Osteoporos Int 22 2011 363 367
11. B. Yanik, C. Turkay, and H. Atalar Hepatotoxicity induced by alendronate therapy Osteoporos Int 18 2007 829 831
12. G. Danan, and C. Benichou Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries J Clin Epidemiol 46 1993 1323 1330
13. C. Benichou, G. Danan, and A. Flahault Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge J Clin Epidemiol 46 1993 1331 1336
14. V.A. Maria, and R.M. Victorino Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis Hepatology 26 1997 664 669
15. G. Kalambokis, P. Manousou, S. Vibhakorn, L. Marelli, E. Cholongitas, and M. Senzolo Transjugular liver biopsy - indications, adequacy, quality of specimens, and complications - a systematic review J Hepatol 47 2007 284 294
16. Papatheodoridis, Patch, Watkinson, Tibballs, and Burroughs Transjugular liver biopsy in the 1990s: a 2-year audit Aliment Pharmacol Ther 1999 1990 603 608
17. B.A. Runyon, D.R. LaBrecque, and S. Anuras The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature Am J Med 69 1980 187 194
18. M.P. Manns, M. Woynarowski, W. Kreisel, Y. Lurie, C. Rust, and E. Zuckerman Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis Gastroenterology 139 2010 1198 1206
19. P. Katsinelos, T. Vasiliadis, P. Xiarchos, F. Patakiouta, K. Christodoulou, and I. Pilpilidis Ursodeoxycholic acid (UDCA) for the treatment of amoxycillin-clavulanate potassium (Augmentin)-induced intra-hepatic cholestasis: report of two cases Eur J Gastroenterol Hepatol 12 2000 365 368
20. A. Wree, A. Dechene, K. Herzer, P. Hilgard, W.K. Syn, and G. Gerken Steroid and ursodesoxycholic acid combination therapy in severe drug-induced liver injury Digestion 84 2011 54 59
21. C.S. Petersen, and K. Thomsen High-dose hydroxychloroquine treatment of porphyria cutanea tarda J Am Acad Dermatol 26 1992 614 619
22. D.O. Clegg, F. Dietz, J. Duffy, R.F. Willkens, E. Hurd, and B.F. Germain Safety and efficacy of hydroxychloroquine as maintenance therapy for rheumatoid arthritis after combination therapy with methotrexate and hydroxychloroquine J Rheumatol 24 1997 1896 1902
23. C. van Heyningen Drug-induced acute autoimmune hepatitis during combination therapy with atorvastatin and ezetimibe Ann Clin Biochem 42 2005 402 404
24. E. Bjornsson, E.I. Jacobsen, and E. Kalaitzakis Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing J Hepatol 56 2012 374 380
25. F. Alvarez, P.A. Berg, F.B. Bianchi, L. Bianchi, A.K. Burroughs, and E.L. Cancado International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 1999 929 938
26. C. Weiler-Normann, and C. Schramm Drug induced liver injury and its relationship to autoimmune hepatitis J Hepatol 55 2011 747 749
27. E. Bjornsson, J. Talwalkar, S. Treeprasertsuk, P.S. Kamath, N. Takahashi, and S. Sanderson Drug-induced autoimmune hepatitis: clinical characteristics and prognosis Hepatology 51 2010 2040 2048